HER2+ Inflammatory Breast Cancer: Adjuvant Strategies

0 Views
administrator
administrator
07/03/23

Debu Tripathy, MD, provides his perspective on delivering appropriate adjuvant therapy given the risk of recurrence in patients with HER2+ inflammatory breast cancer who received surgery.

For more resources and information regarding anticancer targeted therapies: http://targetedonc.com/

Show more

0 Comments Sort By

No comments found

Facebook Comments

Up next